Heparin toxicity in cell culture
- 1 October 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 24 (7) , 742-745
Abstract
Heparin is a universal drug used frequently for its anticoagulant effects. The variabilities in distribution and tendency of heparin to accumulate in tissues cause increased tissue concentrations despite normal serum levels. We aimed to underline the toxic effects of heparin in cell culture make projections for clinical applications. L929 mouse fibroblastic cell line was plated in 96-well culture plates at an initial density of 5000 cells/well. Heparin was prepared in 10 different concentrations (10–300 units/well). Following 3 days of incubation, viabilities were assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay for each concentration in each day and compared. The viability of cells decreased significantly with increasing doses of heparin; at least 50 units/well in the first and second days and at least 20 units/well in the third day (P < 0.05 for each). There was statistically significant difference when the viabilities of cells treated with same heparin concentration in different days were compared (P < 0.05). The authors clearly demonstrated the toxic effects of heparin in cell culture, toxic effects increased as the dose increased. To prevent the unwanted clinical side-effects of heparin further studies should be made and more accurate testing methods should be developed to determine the effective tissue concentration of heparin.Keywords
This publication has 18 references indexed in Scilit:
- May toxicity of amiodarone be prevented by antioxidants? A cell-culture studyJournal of Cardiothoracic Surgery, 2012
- Anticoagulants: Therapeutics, Risks, and Toxicity—Special Emphasis on Heparin-Induced Thrombocytopenia (HIT)Journal of Pharmacy Practice, 2012
- Bleeding complications of unfractionated heparinExpert Opinion on Drug Safety, 2010
- Growth inhibition of bovine pulmonary artery smooth muscle cells following long‐term heparin treatmentJournal of Cellular Physiology, 2009
- Unfractionated Heparin Therapy in Infants and ChildrenPediatrics, 2009
- The effects of heparin and low molecular weight heparins on boneThrombosis Research, 2008
- Lack of correlation between heparin dose and standard clinical monitoring tests in treatment with unfractionated heparin in critically III childrenHaematologica, 2007
- Heparin lowers blood pressure: Biological and clinical perspectivesKidney International, 1995
- Effect of heparin on pulmonary fibroblasts and vascular cells.Thorax, 1992
- Heparin inhibition of smooth muscle cell proliferation: A cellular site of actionJournal of Cellular Physiology, 1986